Loading items....
Funding Opportunities
The University of Colorado Anschutz Cancer Center is pleased to offer pilot grant funding to support the development of exceptional research projects leading to the ultimate conquest of cancer and furthering cancer center objectives.
Sign up to receive weekly updates on Intramural & Extramural Funding Opportunities.
Current Open RFAs
Damon Runyon Cancer Research Foundation
Clinical Investigator Award
This award supports outstanding early-career physician-scientists conducting innovative, patient-oriented cancer research. The award is designed to help investigators establish independent clinical research programs and translate discoveries into improvements in cancer prevention, diagnosis, treatment, and patient outcomes. Research areas may include clinical trials, translational research, outcomes and health services research, epidemiology, and cancer prevention.
Eligibility: Applicants must be early-career physician-scientists who hold an independent Assistant Professor (or equivalent) position at a U.S. institution, have an M.D., D.O., or M.D./Ph.D., have completed subspecialty training, and hold an active U.S. medical license. Applicants must be within four years of their first faculty appointment (on or after July 1, 2023), commit 80% effort to research, and apply with an established mentor in clinical/translational cancer research, cancer prevention, or epidemiology. Investigators with an R01 or equivalent award are not eligible.
Funding: $600,000 over three years ($200,000 annually). No indirect costs are allowed.
Cancer Center LOI Deadline: 5:00 pm MT on Friday, November 6.
Cancer Center Nomination Notification: The week of December 7. Up to three applicants may be nominated.
Sponsor Application Deadline: January 19, 2027.
Please review the RFA and internal LOI submission link below for complete eligibility requirements and application instructions.